Abstracts tagged "Cryofibrinogenemia"

Abstract Number: 2638 • 2013 ACR/ARHP Annual Meeting
Cryoglobulinemia Vasculitis With Or Without Associated Cryofibrinogenemia: A Different Phenotype?
Martin Michaud¹, Guillaume Moulis², Jacques Pourrat¹, Benedicte Puissant¹, Antoine Blancher¹ and Laurent Sailler³, ¹Toulouse University Hospital, University of Toulouse, Toulouse, France, ²Toulouse University Hospital, Clinical Pharmacology Department, University of Toulouse, UMR INSERM-UPS 1027, Toulouse, France, ³Department of Internal Medicine, Toulouse University Hospital, Toulouse, France
Background/Purpose: Cryoglobulin (CryoGl) and cryofibrinogen (CryoFg) are cryoproteins, both responsible for well-described systemic vasculitis. Nevertheless, cryoglobulinemia may be associated with cryofibrinogenemia. Such mixed cryoprotein vasculitis…
Abstract Number: 1622 • 2012 ACR/ARHP Annual Meeting
Characteristics of Patients with Infectious Cryoglobulinemia Vasculitis in the Absence of HCV Infection: Results From the French Nationwide Cryovas Survey
Benjamin Terrier¹, Isabelle Marie², Adeline Lacraz³, Pauline Belenotti⁴, Fabrice Bonnet⁵, Laurent Chiche Sr.⁴, Bruno Graffin Sr.⁶, Arnaud Hot⁷, Jean-Emmanuel Kahn⁸, Thomas Quemeneur⁹, Olivier Hermine Sr.¹⁰, Jean-Marc Léger¹¹, Patricia Senet¹², Emmanuelle Plaisier¹³, Xavier Mariette¹⁴ and Patrice Cacoub Sr.¹⁵, ¹Internal Medicine, Cochin University Hospital, Paris, France, ²Service de médecine interne, CHU de Rouen, Rouen, France., Rouen, France, ³Nephrology, CHU Bordeaux, Bordeaux, France, ⁴Internal Medicine, CHU Marseille, Marseille, France, ⁵Internal Medicine, Bordeaux University Hospital, Bordeaux, France, ⁶Internal Medicine, Metz hospital, Metz, France, ⁷Internal Medicine, Edouard Herriot University Hospital, Lyon, France, ⁸Internal Medicine, Foch Hospital, Suresnes, France, ⁹Internal medicine, CHR de Valenciennes, Valenciennes, France, ¹⁰Department of Hematology, Hôpital Necker, Paris, France, ¹¹Neurology, Hôpital Pitié-Salpêtrière, Neurology, Paris, France, ¹²Dermatology, Tenon hospital, Paris, France, ¹³Nephrology, Tenon Hospital, Paris, France, ¹⁴Rheumatology, Université Paris-Sud, Le Kremlin Bicetre, France, ¹⁵Department of Internal Medicine 2., CHU Pitié-Salpêtrière, Paris, France
Background/Purpose: Hepatitis C virus infection (HCV) is the main cause of mixed cryoglobulinemia vasculitis (CryoVas). Recent data are lacking regarding demographical, clinical and biological features…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].